Clinical Trials
Protalix BioTherapeutics Announces Positive results from Phase II Clinical Trial of alidornase alfa
Protalix BioTherapeutics Inc announced positive interim results from the Company’s phase II clinical trial of alidornase alfa for the treatment of Cystic Fibrosis (CF)...
News
 Hologics Aptima HIV-1 Quant assay gets PMA approval from FDA
Hologic, Inc announced that the U.S. FDA has granted PMA approval for the Company's HIV-1 viral load monitoring assay. The Aptima® HIV-1 Quant assay...
Press Releases
Ardelyx begins two trials for RDX7675 for hyperkalemia treatment
Ardelyx, Inc. a clinical-stage company focused on enhancing the treatment of patients with gastrointestinal and cardiorenal diseases announced the initiation of a Phase 3...
Industry Reports
Factor One Source Pharmacy to Acquire F.A.S.T. Access Rx
Factor One Source Pharmacy and Fast Access Specialty Therapeutics announced today that they have entered into a definitive agreement under which FOSRx will acquire...
Press Releases
Natco Pharma unveils generic version of Hepatitis C drug in Nepal
NATCO launches VELPANAT in Nepal- 1st generic version of Sofosbuvir 400mg/Velpatasvir 100mg fixed dose combination medicine in the country. Natco Pharma...
News
Sanofi Pasteur and MSD end joint vaccines business in Europe
Sanofi and its vaccines global business unit Sanofi Pasteur confirmed today the end of their vaccine joint-venture with MSD (known as Merck & Co....
Industry Reports
Moberg pharma completes acquisition of dermoplast of prestige brands
Moberg Pharma AB has now completed the acquisition of DermoPlast® Prestige Brands, Inc. in accordance with the terms announced on December 6. The purchase...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read